Exozymes (EXOZ) EBIT Margin (2023 - 2024)
Exozymes (EXOZ) has disclosed EBIT Margin for 2 consecutive years, with 3609.93% as the latest value for Q3 2024.
- Quarterly EBIT Margin changed N/A to 3609.93% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 13286.68% through Dec 2024, changed N/A year-over-year, with the annual reading at 598.25% for FY2023, N/A changed from the prior year.
- EBIT Margin for Q3 2024 was 3609.93% at Exozymes, up from 55998.57% in the prior quarter.
- The five-year high for EBIT Margin was 3609.93% in Q3 2024, with the low at 55998.57% in Q4 2023.